Foundation Medicine Reaches 100 Approved Companion Diagnostic Indications
The precision medicine company now has 57 approvals in the US and 43 in Japan for its FoundationOne CDx and FoundationOne Liquid CDx tests.
Read MorePosted by CLP Edit Staff | Dec 8, 2025 | Molecular Diagnostics |
The precision medicine company now has 57 approvals in the US and 43 in Japan for its FoundationOne CDx and FoundationOne Liquid CDx tests.
Read MorePosted by CLP Edit Staff | Dec 8, 2025 | Lymphoma |
Transaction expands Natera’s solid tumor MRD capabilities and adds ultrasensitive phased variant technology with detection below 0.1 parts per million.
Read MorePosted by CLP Edit Staff | Dec 5, 2025 | Analytical Software Systems, Cancer, Molecular Diagnostics |
The collaboration combines AI-based analysis tools with a next-generation sequencing system to support labs performing tumor and liquid biopsy testing.
Read MorePosted by CLP Edit Staff | Dec 2, 2025 | POC Rapid Assays |
The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.
Read MorePosted by Alyx Arnett | Nov 28, 2025 | Information Technology, Sponsored |
Compare leading liver health management platforms that support early detection, streamline clinical workflows, and improve outcomes for patients with liver disease.
Read More